Pathogenesis of Natural SIV and STLV Infections in Humans
Pathogenesis of Natural SIV and STLV Infections in Humans
批准号:
8136013
负责人:
Preston A Marx
金额:
$65.39万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-25 至 2013-08-31
关键词:
Acquired Immunodeficiency SyndromeAcuteAddressAfricaAfricanAmericanAntibodiesBiological AssayBloodBlood CellsBlood TransfusionBlood specimenCameroonCaringChildChronicClinicClinicalCritiquesDataDocumentationEnzyme-Linked Immunosorbent AssayEpidemicEpidemiologyExposure toFeverFundingGoalsHIVHIV-1HIV-2HealthHouseholdHumanImmunologic Deficiency SyndromesInfectionInjection of therapeutic agentKnowledgeLifeMacaca mulattaMedical HistoryModelingMolecular CloningMonkeysMothersNatural HistoryOperative Surgical ProceduresOutcomePathogenesisPathogenicityPeptidesPersonsPhylogenetic AnalysisPlant RootsPopulationPopulations at RiskPrevalenceProceduresPropertyRecording of previous eventsRetroviridaeRiskRisk FactorsRitual compulsionSIVSamplingSierra LeoneSourceStagingTestingToothbrushingVirusVirus DiseasesWestern BlottingWorkbasefollow-upnonhuman primatenovel strategiespet animalpreventsimian human immunodeficiency virussimian virustoothbrushtransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall objective of this project is to assess the risk of emergence of new HIV types from SIV-infected persons in Cameroon. This objective will be obtained by using a new strategy for testing for persons naturally infected with SIV, characterizing their infections and testing for infection in their contacts. Both sexual and causal contacts will be studied. The feasibility of such a project was recently established in preliminary studies using SIV assays in Anglophone Cameroon. We tested 1536 persons attending clinics in and near Kumba, Cameroon for any reason, mostly fevers and other acute illnesses. We used western blots followed by SIV-specific SIV peptide ELISA on all positive and indeterminants results. This new approach identified 6 persons with SIV antibody, 1 SIVcpz, 1 SIVagm and 2 each for SIVrcm and SIVmnd. Aim 1. To screen the general human population in Southwest Cameroon for SIV infections. We will use antibody assays that have already been validated in this region. We will also employ PCR-based testing. Aim 2. To characterize the virologic and phylogenetic properties of SIV either isolated or amplified from humans in Cameroon. For example, we will test G->A hypermutation for testing for adaptation of SIV to humans. Aim 3. To characterize the epidemiology and natural history of SIV infections in humans exposed to simian viruses. We will examine replication, transmission and pathogenesis. Contacts will be tested to determine if these retroviruses are transmissible between humans. The outcome of these infections in humans will be addressed. SIV antibody + persons will have repeated clinical follow-ups. Thus far, SIV-like infections in humans have been dead end infections. This approach will enable us to find and track SIV human infections to assess the risk for emergence of new HIVs. Other groups both French and American are working in Cameroon, but the relatively low sero-prevalence for these viruses warrants other groups being funded to increase the chances of finding active SIV infections in the acute stage. PUBLIC HEALTH RELEVANCE: The root causes for the emergence of the AIDS viruses remain unknown even though this knowledge is vital to prevent the emergence of new epidemics. Although simian immunodeficiency viruses (SIVs) in Africa have been identified as the original source of the AIDS viruses, nothing is known as to why 2 different SIVs suddenly emerged to become epidemic human AIDS viruses in the 20th century. This project will trace the natural history SIV infections in humans to understand how the AIDS epidemic began.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
VIRUS CHALLENGE STOCK PRODUCTION AND STORAGE
-
批准号:8358057
-
项目类别:
-
资助金额:$5.78万
-
财政年份:2011
-
负责人:Preston A Marx
-
依托单位:
DNA VACCINE FOR INDUCTION OF MUCOSAL IMMUNITY
-
批准号:8358091
-
项目类别:
-
资助金额:$5.78万
-
财政年份:2011
-
负责人:Preston A Marx
-
依托单位:
HIGHLY EFFECTIVE CONTROL OF AIDS VIRUS CHALLENGE IN MACAQUES
-
批准号:8358058
-
项目类别:
-
资助金额:$5.78万
-
财政年份:2011
-
负责人:Preston A Marx
-
依托单位:
EFFICACY AND TOXICITY OF CSIC AND RETROCYCLIN IN THE SIV VAGINAL CHALLENGE MODEL
-
批准号:8358131
-
项目类别:
-
资助金额:$5.78万
-
财政年份:2011
-
负责人:Preston A Marx
-
依托单位:
Primate Studies
-
批准号:8720871
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2011
-
负责人:Preston A Marx
-
依托单位:
PATHOGENESIS OF NATURAL SIV AND STLV INFECTIONS IN HUMANS
-
批准号:8358130
-
项目类别:
-
资助金额:$5.78万
-
财政年份:2011
-
负责人:Preston A Marx
-
依托单位:
ISOLATION OF A NEW HIV-2 GROUP IN THE US
-
批准号:8358116
-
项目类别:
-
资助金额:$5.78万
-
财政年份:2011
-
负责人:Preston A Marx
-
依托单位:
NHP PILOT STUDY OF A NOVEL PROTEIN ADJUVANT FOR VACCINES AGAINST HUMAN PATHOGENS
-
批准号:8358134
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2011
-
负责人:Preston A Marx
-
依托单位:
HIV ENV EPITOPE ENGINEERING
-
批准号:8173047
-
项目类别:
-
资助金额:$3.94万
-
财政年份:2010
-
负责人:Preston A Marx
-
依托单位:
DNA VACCINE FOR INDUCTION OF MUCOSAL IMMUNITY
-
批准号:8172993
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:Preston A Marx
-
依托单位:
EFFICACY AND TOXICITY OF CSIC AND RETROCYCLIN IN THE SIV VAGINAL CHALLENGE MODEL
-
批准号:8173044
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:Preston A Marx
-
依托单位:
HIGHLY EFFECTIVE CONTROL OF AIDS VIRUS CHALLENGE IN MACAQUES
-
批准号:8172951
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:Preston A Marx
-
依托单位:
ELICITATION OF BROAD IMMUNITY USING VLPS WITH CONSENSUS ENVS
-
批准号:8173016
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:Preston A Marx
-
依托单位:
VIRUS CHALLENGE STOCK PRODUCTION AND STORAGE
-
批准号:8172950
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:Preston A Marx
-
依托单位:
NHP PILOT STUDY OF A NOVEL PROTEIN ADJUVANT FOR VACCINES AGAINST HUMAN PATHOGENS
-
批准号:8173048
-
项目类别:
-
资助金额:$3.94万
-
财政年份:2010
-
负责人:Preston A Marx
-
依托单位:
PATHOGENESIS OF NATURAL SIV AND STLV INFECTIONS IN HUMANS
-
批准号:8173043
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:Preston A Marx
-
依托单位:
ANTIBODY EFFECTOR FUNCTION PROTECTION AGAINST HIV-1
-
批准号:8172954
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:Preston A Marx
-
依托单位:
PALOMA PHARMA 529 TREATMENT FOR SIV STUDY
-
批准号:8173042
-
项目类别:
-
资助金额:$6.18万
-
财政年份:2010
-
负责人:Preston A Marx
-
依托单位:
SIMIAN RETROVIRUS VACCINE FOR NON-HUMAN PRIMATES
-
批准号:7958652
-
项目类别:
-
资助金额:$6.04万
-
财政年份:2009
-
负责人:Preston A Marx
-
依托单位:
HIGHLY EFFECTIVE CONTROL OF AIDS VIRUS CHALLENGE IN MACAQUES
-
批准号:7958614
-
项目类别:
-
资助金额:$6.04万
-
财政年份:2009
-
负责人:Preston A Marx
-
依托单位:
海外基金